Results 141 to 150 of about 1,127,075 (266)

AI-Powered Lesion-Level Tumor Growth Inhibition Modeling Improves Model Stability and Prognostic Association With PFS. [PDF]

CPT Pharmacometrics Syst Pharmacol
Liu A, Duan C, Maresca K, Pithavala YK, Lu JT, Guo CC, Hibma JE.   +6 more
europepmc   +1 more source

CONJUNCTIVAL LESIONS [PDF]

British Journal of Ophthalmology, 1963
openaire   +2 more sources

Advancing Age Modulates Associations Between Cognitive Impairment and Brain Volumes in Early MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Cognitive impairment is common in multiple sclerosis (MS), but manifestations following the first demyelinating event are relatively unexplored. We investigated cross‐sectional associations between magnetic resonance imaging (MRI)–derived brain volumes and the presence of cognitive impairment outcomes five years after the first ...
Piriyankan Ananthavarathan, Marco Pitteri, Michael Foster, Sara Collorone, Sara Salama, Elisa Colato, Ferran Prados, Baris Kanber, Marios Yiannakas, Claudia A. M. Gandini Wheeler‐Kingshott, Indran Davagnanam, Frederik Barkhof, Declan Chard, Olga Ciccarelli, Ahmed Toosy   +14 more
wiley   +1 more source

Cavernous hemangioma mimicking schwannoma in the sacral intervertebral foramen: A case report. [PDF]

J Int Med Res
Li Z, Han C, Xiong Z, Wang Z, Tan M, Yu J, Ma M, Wang W, Wang Y, Di G, Jiang X.   +10 more
europepmc   +1 more source

Prognostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in ALD‐Related Myelopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak, Marije M. C. Voermans, Hans Heijst, Charlotte E. Teunissen, Marc Engelen   +4 more
wiley   +1 more source

Rare Extrahepatic Metastasis of Hepatocellular Carcinoma to the Left Triangular Ligament: A Case Report. [PDF]

Surg Case Rep
Tsuda A, Hanaki T, Ishii H, Uehira K, Yoshida J, Kishino M, Morimoto M, Murakami Y, Tokuyasu N, Sakamoto T, Fujiwara Y.   +10 more
europepmc   +1 more source

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec, Elif Everest, Melih Tutuncu, Ugur Bilge, Sabahattin Saip, Ugur Uygunoglu, Aksel Siva   +6 more
wiley   +1 more source

US Retina Specialists' Preferences for Geographic Atrophy Treatment. [PDF]

Clin Ophthalmol
Csaky K, Pepio AM, Thomas C, Levitan B, Garg S, Tran N, Irony I, Krucien N, Doldos A, Whitty JA.   +9 more
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

See the small lesions: Frequency-guided spatial debiasing GAN for multimodal medical image fusion. [PDF]

iScience
Zhou T, Wang J, Lu H, Zhang M, Zhang Z, Yu H, Zheng P.   +6 more
europepmc   +1 more source